AACP
HQY icon

Advantage Alpha Capital Partners’s HealthEquity HQY Stock Holding History

Advantage Alpha Capital Partners’s Portfolio HQY Stock Details HQY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,742
Closed -$4.81M – 56
2025
Q3 		$4.81M Buy
50,742
+6,028
+13% +$567K 1.45% 9
2025
Q2 		$4.68M Sell
44,714
-17,202
-28% -$1.63M 1.26% 23
2025
Q1 		$5.47M Sell
61,916
-10,097
-14% -$1.04M 1.34% 18
2024
Q4 		$6.91M Sell
72,013
-11,079
-13% -$1.03M 1.63% 13
2024
Q3 		$6.8M Sell
83,092
-22,168
-21% -$1.71M 1.55% 15
2024
Q2 		$9.07M Sell
105,260
-24
-0% -$1.94K 1.98% 3
2024
Q1 		$8.59M Buy
105,284
+69,760
+196% +$5.45M 1.62% 11
2023
Q4 		$2.36M Sell
35,524
-60,777
-63% -$4.21M 0.45% 82
2023
Q3 		$7.03M Sell
96,301
-27,038
-22% -$1.83M 1.48% 24
2023
Q2 		$7.79M Buy
123,339
+761
+0.6% +$44.1K 1.56% 17
2023
Q1 		$7.2M Buy
122,578
+45,637
+59% +$2.77M 1.5% 18
2022
Q4 		$4.74M Sell
76,941
-46,021
-37% -$3.09M 0.96% 39
2022
Q3 		$8.26M Sell
122,962
-25,541
-17% -$1.62M 1.52% 26
2022
Q2 		$9.12M Sell
148,503
-10,591
-7% -$678K 1.57% 19
2022
Q1 		$10.7M Buy
159,094
+8,246
+5% +$445K 1.61% 7
2021
Q4 		$6.67M Buy
150,848
+71,949
+91% +$4.19M 0.95% 49
2021
Q3 		$5.11M Buy
78,899
+29,432
+59% +$2.04M 0.93% 47
2021
Q2 		$3.98M Buy
49,467
+2,438
+5% +$186K 0.77% 69
2021
Q1 		$3.2M Sell
47,029
-19,310
-29% -$1.52M 0.67% 76
2020
Q4 		$4.62M Sell
66,339
-59,500
-47% -$3.7M 1.01% 46
2020
Q3 		$6.46M Buy
125,839
+20,241
+19% +$1.11M 1.49% 25
2020
Q2 		$6.2M Buy
105,598
+26,344
+33% +$1.46M 1.45% 20
2020
Q1 		$4.01M Sell
79,254
-27,387
-26% -$1.82M 1.43% 23
2019
Q4 		$7.9M Buy
+106,641
New +$6.65M 2.13% 4

Other funds holding HQY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Advantage Alpha Capital Partners's HQY Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of HealthEquity (HQY) in Q4 2025, closing a stake of 50,742 shares — an estimated $4.81M sold.

Advantage Alpha Capital Partners first reported a position in HQY in Q4 2019 and held it in 24 quarters. The position peaked at $10.7M in Q1 2022. 512 funds tracked by Wall St. Rank hold HQY as of Q4 2025.

  • Advantage Alpha Capital Partners reported no remaining HealthEquity position as of Q4 2025 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 50,742 HealthEquity shares in Q4 2025, an estimated $4.81M.
  • Advantage Alpha Capital Partners first reported a position in HealthEquity in Q4 2019 and held it in 24 quarters.
  • Advantage Alpha Capital Partners's HealthEquity position peaked at $10.7M in Q1 2022.
  • 512 funds tracked by Wall St. Rank held HealthEquity as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.